<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-id><journal-title-group><journal-title>Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)</journal-title></journal-title-group><issn publication-format="electronic">1990-472X</issn><publisher><publisher-name>Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4485</article-id><article-id pub-id-type="doi">10.18499/1990-472X-2011-0-44-249-250</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>CLINICAL EXPERIENCE OF MODERN ANTIPARKINSONIAN DRUGS</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Shchegolev</surname><given-names>A Y</given-names></name><bio></bio><email>Shegolev11@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khorvat</surname><given-names>N V</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">GUZ Regional hospital № 2 of Lipetsk</aff><pub-date date-type="epub" iso-8601-date="2011-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2011</year></pub-date><issue>44</issue><fpage>249</fpage><lpage>250</lpage><history><pub-date date-type="received" iso-8601-date="2020-04-25"><day>25</day><month>04</month><year>2020</year></pub-date></history><permissions><copyright-statement>Copyright © 2011, Научно-медицинский вестник Центрального Черноземья</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract>Illness of Parkinsona concerns one of the most widespread chronic neurodegeneration diseases which results both in the expressed neurologic infringements, and to considerable decrease in social activity and quality of life of patients. Use modern antiparkinsonic preparations, considerably improves the forecast for life of the patient, quality of his life, considerably defers, appointment L-dopa medicines preparations and slows down disease progressing.</abstract><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона</kwd><kwd>дискинезии</kwd><kwd>противопаркинсонические препараты</kwd><kwd>ропинерол</kwd><kwd>леводопа</kwd><kwd>качество жизни</kwd></kwd-group></article-meta></front><body></body><back/></article>
